F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe; The New York Times, May 5, 2026

Christina Jewett , The New York Times; F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe

"Officials at the Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, a spokesman for the Department of Health and Human Services confirmed.

The studies, which cost millions of dollars in public funds, were conducted by scientists at the agency, who worked with data firms to analyze millions of patient records. They found serious side effects to be very rare.

In October, the scientists were directed to withdraw two Covid-19 vaccine studies that had been accepted for publication in medical journals. In February, top F.D.A. officials did not sign off on submitting abstracts about studies of Shingrix, a shingles vaccine, to a major drug safety conference.

The withdrawal of the studies is the latest step by the administration to try to limit access to vaccines. It has sharply cut research funding for vaccine development, released unvetted information casting doubt on vaccines, and blocked other information supporting their safety, most recently a paper on Covid vaccine effectiveness by career scientists from the Centers for Disease Control and Prevention."

Open access to scientific publications must become a reality by 2020 - Robert-Jan Smits; Horizon: The EU Research & Innovation Magazine, March 23, 2018

Joanna Roberts, Horizon: The EU Research & Innovation Magazine; Open access to scientific publications must become a reality by 2020 - Robert-Jan Smits

"A lot of lip service is being paid to making scientific papers free to access but when it comes to action there is a lot of hypocrisy, according to Robert-Jan Smits, the EU's outgoing director-general for research, science and innovation. He has recently been appointed the EU's special envoy on open access, tasked with helping make all publicly funded research in Europe freely available by 2020.

Making scientific publications free to read is a big change in a world dominated by subscription journals. Why is it so important that science publications become open access?

At the moment we are putting a lot of public money at national, European and global level into science. But we don’t have free access to the published results of the research we fund because this is locked behind paywalls. We have to spend an enormous amount of money each year on subscriptions to journals where scientific articles are published and on making these results immediately available in open access. Imagine if all the billions we are now putting into these expensive subscription journals could be put into research. That’s also why in the 3 O’s policy of Commissioner Moedas (the EU Commissioner for Research, Science and Innovation), open access is mentioned explicitly as a top priority within the open science agenda.

'Open access to research results will help to have more and faster innovations, to have quicker solutions to the problems we are facing and to allow further research to be carried out.

'There is with regard to open access also another dimension, to which we don't pay a lot of attention. If we want to see that also in the developing countries a science base is being built, we should give these countries easy and low-cost access to scientific publications because these countries just cannot afford to pay for these expensive subscription journals.'"